• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

V600E-positive cells as molecular markers of bone marrow disease in pediatric Langerhans cell histiocytosis.

作者信息

Kudo Ko, Toki Tsutomu, Kanezaki Rika, Tanaka Tatsuhiko, Kamio Takuya, Sato Tomohiko, Sasaki Shinya, Imamura Masaru, Imai Chihaya, Ando Kumiko, Kakuda Harumi, Doi Takehiko, Kawaguchi Hiroshi, Irie Masahiro, Sasahara Yoji, Tamura Akihiro, Hasegawa Daiichiro, Itakura Yosuke, Watanabe Kenichiro, Sakamoto Kenichi, Shioda Yoko, Kato Motohiro, Kudo Kazuko, Fukano Reiji, Sato Atsushi, Yagasaki Hiroshi, Kanegane Hirokazu, Kato Itaru, Umeda Katsutsugu, Adachi Souichi, Kataoka Tatsuki, Kurose Akira, Nakazawa Atsuko, Terui Kiminori, Ito Etsuro

机构信息

Department of Pediatrics, Hirosaki University Graduate School of Medicine, Hirosaki.

Department of Pediatrics, Niigata University Graduate School of Medical and Dental Sciences, Niigata.

出版信息

Haematologica. 2022 Jul 1;107(7):1719-1725. doi: 10.3324/haematol.2021.279857.

DOI:10.3324/haematol.2021.279857
PMID:35295077
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9244822/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96f1/9244822/a507ab3190da/1071719.fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96f1/9244822/a507ab3190da/1071719.fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96f1/9244822/a507ab3190da/1071719.fig1.jpg

相似文献

1
V600E-positive cells as molecular markers of bone marrow disease in pediatric Langerhans cell histiocytosis.V600E阳性细胞作为儿童朗格汉斯细胞组织细胞增多症骨髓疾病的分子标志物。
Haematologica. 2022 Jul 1;107(7):1719-1725. doi: 10.3324/haematol.2021.279857.
2
Cellular morphology of BRAF V600E-positive Langerhans cell histiocytosis.BRAF V600E 阳性朗格汉斯细胞组织细胞增生症的细胞形态学
Blood. 2015 Oct 8;126(15):1857. doi: 10.1182/blood-2015-07-656900.
3
Association between clinicopathologic characteristics and BRAF expression in Chinese patients with Langerhans cell histiocytosis.中国朗格汉斯细胞组织细胞增生症患者临床病理特征与 BRAF 表达的相关性。
Thorac Cancer. 2019 Oct;10(10):1984-1992. doi: 10.1111/1759-7714.13179. Epub 2019 Aug 23.
4
[Langerhans cell histiocytosis of the stomach with BRAF-V600E-mutation: case report and review of the literature].[伴有BRAF-V600E突变的胃朗格汉斯细胞组织细胞增多症：病例报告及文献复习]
Z Gastroenterol. 2015 Apr;53(4):302-5. doi: 10.1055/s-0034-1399058. Epub 2015 Apr 10.
5
The Value of BRAF VE1 Immunoexpression in Pediatric Langerhans Cell Histiocytosis.BRAF VE1免疫表达在儿童朗格汉斯细胞组织细胞增多症中的价值
Fetal Pediatr Pathol. 2022 Aug;41(4):558-567. doi: 10.1080/15513815.2020.1857483. Epub 2020 Dec 9.
6
Circulating cell-free BRAF as a biomarker in children with Langerhans cell histiocytosis.循环无细胞 BRAF 作为朗格汉斯细胞组织细胞增生症患儿的生物标志物。
Br J Haematol. 2017 Aug;178(3):457-467. doi: 10.1111/bjh.14695. Epub 2017 Apr 25.
7
Assessment of BRAF mutation in pulmonary Langerhans cell histiocytosis in tissue biopsies and bronchoalveolar lavages by droplet digital polymerase chain reaction.通过液滴数字聚合酶链反应评估组织活检和支气管肺泡灌洗中肺朗格汉斯细胞组织细胞增生症的BRAF突变
Virchows Arch. 2018 Feb;472(2):247-258. doi: 10.1007/s00428-017-2185-0. Epub 2017 Jul 15.
8
Vemurafenib provides a rapid and robust clinical response in pediatric Langerhans cell histiocytosis with the BRAF V600E mutation but does not eliminate low-level minimal residual disease per ddPCR using cell-free circulating DNA.维莫非尼在携带 BRAF V600E 突变的儿童朗格汉斯细胞组织细胞增生症中提供了快速而显著的临床应答，但使用游离循环细胞 DNA 的 ddPCR 并不能消除低水平的微小残留病灶。
Int J Hematol. 2021 Dec;114(6):725-734. doi: 10.1007/s12185-021-03205-8. Epub 2021 Aug 12.
9
BRAF V600 mutations in Langerhans cell histiocytosis with a simple and unique assay.采用简单且独特的检测方法检测朗格汉斯细胞组织细胞增多症中的BRAF V600突变。
Diagn Pathol. 2016 Apr 19;11:39. doi: 10.1186/s13000-016-0489-z.
10
[Bone and soft tissue Langerhans cell histiocytosis with multinucleated giant cells and BRAF V600E mutation].伴有多核巨细胞及BRAF V600E突变的骨与软组织朗格汉斯细胞组织细胞增多症
Rev Esp Patol. 2021 Apr-Jun;54(2):136-140. doi: 10.1016/j.patol.2018.08.003. Epub 2018 Oct 12.

引用本文的文献

1
A case report of infantile fibrosarcoma with BRAF gene mutation with incomplete intestinal obstruction.1例伴有BRAF基因突变及不完全性肠梗阻的婴儿纤维肉瘤病例报告
Front Oncol. 2025 Jan 29;15:1492654. doi: 10.3389/fonc.2025.1492654. eCollection 2025.
2
Early chemotherapeutic intervention to avoid thyroidectomy in pediatric Langerhans cell histiocytosis with thyroid involvement accompanying tracheal stenosis: a report of two cases.早期化疗干预以避免伴有气管狭窄的小儿朗格汉斯细胞组织细胞增生症甲状腺受累行甲状腺切除术：两例报告。
Int J Hematol. 2024 Jan;119(1):99-103. doi: 10.1007/s12185-023-03662-3. Epub 2023 Sep 23.
3

本文引用的文献

1
Histiocytic disorders.组织细胞增生症。
Nat Rev Dis Primers. 2021 Oct 7;7(1):73. doi: 10.1038/s41572-021-00307-9.
2
BRAF-induced senescence drives Langerhans cell histiocytosis pathophysiology.BRAF 诱导的衰老驱动朗格汉斯细胞组织细胞增生症的发病机制。
Nat Med. 2021 May;27(5):851-861. doi: 10.1038/s41591-021-01304-x. Epub 2021 May 6.
3
Langerhans cell histiocytosis.朗格汉斯细胞组织细胞增生症。
Detection of BRAF V600E mutation in radiological Langerhans cell histiocytosis-associated neurodegenerative disease using droplet digital PCR analysis.
应用液滴数字 PCR 分析检测影像学表现的朗格汉斯细胞组织细胞增生症相关神经退行性疾病中的 BRAF V600E 突变。
Int J Hematol. 2023 Jul;118(1):119-124. doi: 10.1007/s12185-023-03588-w. Epub 2023 Apr 3.
4
Optimal timing of liver transplantation for liver cirrhosis caused by sclerosing cholangitis in a patient with Langerhans cell histiocytosis: a case report.朗格汉斯细胞组织细胞增生症患者硬化性胆管炎所致肝硬化肝移植的最佳时机：病例报告。
Int J Hematol. 2023 May;117(5):759-764. doi: 10.1007/s12185-022-03500-y. Epub 2022 Dec 5.
5
Clinicogenomic associations in childhood Langerhans cell histiocytosis: an international cohort study.儿童朗格汉斯细胞组织细胞增生症的临床基因组关联：一项国际队列研究。
Blood Adv. 2023 Feb 28;7(4):664-679. doi: 10.1182/bloodadvances.2022007947.
Blood. 2020 Apr 16;135(16):1319-1331. doi: 10.1182/blood.2019000934.
4
Langerhans-Cell Histiocytosis.朗格汉斯细胞组织细胞增多症
N Engl J Med. 2018 Aug 30;379(9):856-868. doi: 10.1056/NEJMra1607548.
5
Histiocytic cell neoplasms involving the bone marrow: summary of the workshop cases submitted to the 18th Meeting of the European Association for Haematopathology (EAHP) organized by the European Bone Marrow Working Group, Basel 2016.累及骨髓的组织细胞肿瘤：对 2016 年欧洲血液病理学协会（EAHP）第 18 次会议上提交的欧洲骨髓工作组病例的研讨会总结，会议在巴塞尔举行。
Ann Hematol. 2018 Nov;97(11):2117-2128. doi: 10.1007/s00277-018-3436-0. Epub 2018 Aug 6.
6
Functional evidence for derivation of systemic histiocytic neoplasms from hematopoietic stem/progenitor cells.造血干/祖细胞衍生系统性组织细胞肿瘤的功能证据。
Blood. 2017 Jul 13;130(2):176-180. doi: 10.1182/blood-2016-12-757377. Epub 2017 May 31.
7
Hematopoietic origin of Langerhans cell histiocytosis and Erdheim-Chester disease in adults.成人朗格汉斯细胞组织细胞增多症和 Erdheim-Chester 病的造血起源
Blood. 2017 Jul 13;130(2):167-175. doi: 10.1182/blood-2016-12-757823. Epub 2017 May 16.
8
Intensified and prolonged therapy comprising cytarabine, vincristine and prednisolone improves outcome in patients with multisystem Langerhans cell histiocytosis: results of the Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study.由阿糖胞苷、长春新碱和泼尼松龙组成的强化延长治疗可改善多系统朗格汉斯细胞组织细胞增多症患者的预后：日本朗格汉斯细胞组织细胞增多症研究组-02方案研究结果
Int J Hematol. 2016 Jul;104(1):99-109. doi: 10.1007/s12185-016-1993-3. Epub 2016 Apr 4.
9
Bone marrow infiltration in Langerhan's cell histiocytosis - An unusual but important determinant for staging and treatment.朗格汉斯细胞组织细胞增多症中的骨髓浸润——分期及治疗的一个不常见但重要的决定因素
Int J Hematol Oncol Stem Cell Res. 2015 Oct 1;9(4):193-7.
10
CD1c+ blood dendritic cells have Langerhans cell potential.CD1c+血液树突状细胞具有朗格汉斯细胞潜能。
Blood. 2015 Jan 15;125(3):470-3. doi: 10.1182/blood-2014-08-593582. Epub 2014 Oct 28.